Company

HysensBio History

    • 1999

    • · Began scientific research on dentin regeneration
    • 2016

    • · Confirmed regenerative function of dentin regenerative protein
    • · Established HysensBio Co., Ltd.
    • · Certified as venture company
    • 2017

    • · Established Corporate R&D Center
    • · Developed the novel KH001 functional peptide
    • · Funded by Korean Ministry of Commerce Industry & Energy (KRW 2B)
    • 2018

    • · Funded by Korea Investment Partners: Series A (KRW 2B)
    • · Registered patent related to dentin regeneration
    • 2019

    • · Funded by Korea Investment Partners, DAYLI Partners, Timefolio Asset Management: Series B (KRW 7B)
    • · New Technology Award, Ministry of Commerce Industry & Energy (Nov 2019)
    • 2020

    • · Grand prize in Creative Innovation of 50+ Awards, LINA Korea
    • · Selected as Potential Unicorn Corporate by Ministry of SMEs & Startups
    • · Applied patent related to periodontium regeneration
    • · Approved of IND for clinical trials